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http:WHAT THIS PAPER ADDS
The evidence on the comparison of endovascular repair with open surgical repair of popliteal artery aneurysms
remains inconclusive. Here, ﬁndings from the largest meta-analysis on this topic to date, based on 652 cases, are
reported. The results suggest that patient outcomes after endovascular repair may be equal to open surgical
repair, and the endovascular technique appears to be a viable alternative to open surgery. Nevertheless, current
evidence on endovascular repair is limited and further research is necessary.Objective/Background: Over the last two decades endovascular repair (EVR) of popliteal artery aneurysms has
emerged as a treatment alternative to conventional open surgical repair (OSR). The aim of this review was to
evaluate the safety and efﬁciency of each repair method, comparing the following outcomes after EVR and OSR:
(i) primary patency; (ii) operating time; (iii) length of hospital stay; (iv) peri-operative complications; (v) limb
salvage; and (vi) patient survival.
Methods: The PubMed and Cochrane Central Register of Controlled Trials were searched for publications that
compared outcomes after EVR and OSR (last search November 2014). Randomized controlled trials (RCTs),
prospective and retrospective observational cohort studies were included. The quality of studies was evaluated
using the NewcastleeOttawa scale and the Grading of Recommendations Assessment, Development and
Evaluation (GRADE) system. Random effect models were employed to estimate odds ratios (ORs), mean
differences, and hazard ratios (HRs).
Results: One RCT combined with a prospective cohort study and four retrospective cohort studies with an overall
total of 652 cases (236 EVR, 416 OSR) were identiﬁed. GRADE quality of evidence was low or very low for all
outcomes. After a median follow up of 33 months, patients who received EVR showed equal primary patency
rates to patients who received OSR (HR 1.46, 95% conﬁdence interval [CI] 0.92e2.33). Lengths of operation and
hospitalization were signiﬁcantly shorter following EVR; rates of 30 day graft thrombosis (OR 3.16, 95% CI 1.31e
7.62) and 30 day re-intervention (OR 2.15, 95% CI 1.02e4.55) were signiﬁcant higher for patients who received
EVR compared with those who received OSR. There was no effect on mortality (OR 2.31, 95% CI 0.37e14.49) or
limb loss (OR 0.59, 95% CI 0.16e2.15).
Conclusion: EVR of popliteal artery aneurysm showed mid-term results comparable to open surgery and appears
to be a safe alternative to OSR. However, the existing empirical evidence base is too fragmentary to draw ﬁrm
conclusions. Further research and the introduction of population based registries will be needed to allow reliable
evaluation of EVR.
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Popliteal artery aneurysm (PAA) accounts for 70% of all
peripheral arterial aneurysms; its prevalence is estimated to
be 1% in men aged 60e80 years.1,2 PAA affects women less
frequently, with a male to female ratio of 20:1.3
The natural course of PAA includes a high incidence of
acute and chronic thromboembolic complications. Owing to
chronic thromboembolism, 50% of patients present with
such symptoms as intermittent claudication, rest pain, blue
toe syndrome, or acral necrosis.1 Approximately 30% of
untreated patients with PAA experience acute thrombosis
and distal embolization, with amputation rates of up to
20%.3e5 Another limb threatening complication of PAA is
rupture, which occurs in approximately 2% of patients.3 In
contrast, early elective treatment of PAA with open surgery
is associated with limb salvage rates of 86e99% and pri-
mary patency rates of 66e86% over 5 years.3
Over the last 50 years, PAAs have commonly been
repaired by proximal and distal ligation of the aneurysmal
arterial segment combined with an autologous vein
bypass.6 In 1994, Marin et al. described the ﬁrst stent graft
implantation into a PAA.7 Since then, endovascular repair
(EVR) of PAAs has evolved as a new treatment alternative to
conventional open surgical repair (OSR).
Previous studies assumed that EVR provides similar re-
sults to OSR.8e12 To determine if one treatment method is
superior to the other, the mid-term outcomes after EVR and
OSR were compared in this systematic review. To evaluate
the safety and efﬁciency of each repair method, primary
patency, limb salvage, peri-operative complications, and
patient survival rates were analyzed.
MATERIALS AND METHODS
Eligibility criteria
Randomized controlled trials (RCTs), prospective and
retrospective observational cohort studies that compared
outcomes of EVR and OSR of PAA were considered for in-
clusion. Reports of patients of every age and sex with
asymptomatic, symptomatic or acute ischemic PAA
requiring an elective or emergency treatment were taken
into account.
Surgical aneurysm repair techniques included endoa-
neurysmorrhaphy, proximal and distal ligation of the
popliteal artery or exclusion of the aneurysm. For recon-
struction, autologous venous or prosthetic graft material
was used through a medial or posterior approach. In the
endovascular group, all stent graft designs and all stent
graft manufactures were accepted.Outcomes of interest
The primary outcome was the primary patency rate after
aneurysm repair. Primary patency was deﬁned as uninter-
rupted patency following initial graft deployment.13
Secondary outcomes were all cause mortality, limb loss,
procedure duration, length of hospitalization, and peri-
operative complications (30 day graft thrombosis and 30day re-intervention). The end point limb loss implied below
and above knee amputations. Peri-operative complications
were classiﬁed as treatment complications arising in the
ﬁrst 30 days after intervention.
Search strategy and study selection
A systematic literature search of PubMed and the Cochrane
Central Register of Controlled Trials was performed, using the
search term “popliteal aneurysm” in the title or abstract. To
identify additional reviews the reference lists of the articles
obtained weremanually examined.The search was restricted
to studies published between January 1994 and November
2014, and to the English and German language.
After screening the title and abstracts, and deleting du-
plicates, matching full text references were retrieved. Two
authors (MVS and HT) independently assessed the reports
for inclusion.
Data extraction
Two authors (MVS and HT) independently extracted the
study data. Data for mortality, graft patency, and limb loss
were collected over the peri-operative and follow up
period. Peri-operative variables, including operation time,
length of hospitalization, 30 day graft thrombosis, and 30
day re-intervention, were also noted. Technical success
rates following EVR and stent graft complications (migra-
tion, kinking, and endoleak) were extracted. Additionally,
individual patient characteristics were extracted, including
total number of patients, mean or median age, sex, symp-
tomatic presentation, and comorbidities. Medication with
antiplatelet and anticoagulant drugs was also noted.
Assessment of study quality and evidence rating
The quality of studies was assessed independently by two
authors (MVS and HT) using the NewcastleeOttawa Scale
(NOS).14 The NOS evaluates studies by patient selection
methods, comparability of study groups, and assessment of
outcome. Studies with a score of more than six stars from a
maximum of nine were considered to be of higher quality.
The quality of evidence was assessed independently by
two authors (MVS and HT) using the Grading of Recom-
mendations Assessment, Development and Evaluation
(GRADE) system, as recommended by the Cochrane
collaboration.15 Study quality was evaluated by risk of bias,
indirectness of evidence, heterogeneity, imprecision of re-
sults, and publication bias. The presence of one or more
serious limitations resulted in a very low grade of evidence.
Cohort studies usually have a low quality of evidence.
Statistical analysis
For this meta-analysis, the recommendations of the
Cochrane Collaboration for reporting systematic reviews
and meta-analyses (Preferred Reporting Items for System-
atic Reviews and Meta-Analyses [PRISMA]) were followed.16
Statistical analyses were carried out using RevMan version
5.1.6. (Cochrane Collaboration, Oxford, UK).
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pooled with a summary statistic and compared in a meta-
analysis with a 95% conﬁdence interval (CI). The patients’
baseline characteristics and peri-operative details given as
dichotomous or continuous data were combined with an
odds ratio (OR) or mean difference (MD). Analyzing the
outcomes of mortality, limb loss, and primary patency in
different time intervals, variables were extracted either
from the published text or given KaplaneMeier curves.
Missing data for desired time intervals were calculated on
the recommendations of Tierney et al. for time to event
data.17 A ManteleHaenszel chi-square method in a random
effects model was used to combine the ORs of each end
point. An OR > 1 meant that an event was more likely to
follow OSR. Additionally, primary patency rates were
analyzed as hazard ratios (HRs), as described by Tierney
et al.17 Subsequently, the HRs were compared with the
generic inverse variance method of RevMan. At present,
the HR is considered to be the most appropriate statistical
method to analyze time to event data by reﬂecting the
general censorship of patients during the observation
period.17,18
Owing to the low number of identiﬁed studies (see
“Results”), meta-regression and sensitivity analysis could
not be conducted in a reasonable statistical manner.
RESULTS
Study selection and study characteristics
The literature search identiﬁed 11 studies comparing the
outcomes of OSR and EVR of PAAs. Three articles were
excluded: the ﬁrst only published the results of primary
patency after 30 days and after 1 yeardno KaplandMeier
curve or any secondary outcome parameter was published;
in the second study, the study population was
inhomogeneousd136 OSR patients and only 3 EVR patients
were examined; the third study did not report on endo-
vascular stent graft implantation into the popliteal artery,
but rather about a different endovascular aneurysm repair
technique with aneurysm coiling and in situ venous bypass,
and was therefore also excluded.19e21
The literature search identiﬁed three articles providing an
update on previously published studies comparing EVR and
OSR. In 2005, Antonello et al. published a RCT with data
from 1999 to 2003.22 Two years later they combined this
RCT with a prospective cohort study and published data
from 1999 to 2006.23 Similarly, in 2012, Pulli et al. published
a study of EVR and OSR of PAAs, which contained data from
2005 to 2010.24 One year later, in 2013, they released a new
study with patient data from 2000 to 2011.25 Stone et al.
also published two studies, one in 2005 and one in
2013.26,27 The ﬁrst dealt with patient records from 1995 to
2004,26 and the second with data from 2001 to 2011.27 The
ﬁrst series of studies was excluded22,24,26; only the most
recent studies with the lengthiest follow up data were
selected for this analysis.
Overall, ﬁve studies were included, containing a total of
652 PAA repairs (236 EVR, 416 OSR; Fig. 1 andTable 1).23,25,27e29 The ﬁve studies varied in study design:
one was a RCT combined with a prospective comparative
study23; the other four were retrospective cohort studies
containing the data of symptomatic and asymptomatic pa-
tients.25,27e29 Only one cohort study separated outcome
measurements of elective and emergency cases.28
The indications for PAA treatment were identical in all
studies. Patients with asymptomatic aneurysms with a
diameter >20 mm were treated; in symptomatic patients
the indication for surgery was unrelated to the diameter of
the aneurysm.
Different stent grafts were used in each study: in three
studies, Hemobahn and Viabahn (Gore, Falstaff, AZ, USA)
stent grafts were used23,25,28; in the remaining two, only
Viabahn (Gore) stent grafts were implanted into the popli-
teal artery.27,29 There were no differences in the operative
strategy between the selected studies: the bypass material
of choice was the autologous greater saphenous vein; only
in rare cases were polytetraﬂuorethylene grafts used.
Patient characteristics differed signiﬁcantly in all four
cohort studies. Only Antonello et al. provided a study
population without signiﬁcant differences between baseline
characteristics.22,23
There were four low quality articles (NOS score ¼ 5) and
one moderate quality article (NOS score ¼ 7) (Table 2).
GRADE assessment of all outcomes was “low” or “very low”
(Table 2).
Patient characteristics
In total, 597 patients with a mean age of 71 years (range
51e83 years) were treated for 652 popliteal aneurysms
(236 EVR, 416 OSR; Table 3). There were 560 men (94%; 204
EVR; 356 OSR) and 37 women (19 EVR; 18 OSR). De-
mographic data differed signiﬁcantly between the OSR and
EVR groups with regard to age and clinical status. Patients
undergoing EVR were signiﬁcantly older (75  6 years vs.
68  3 years; MD 6.95, 95% CI 4.04e9.86 [p < .001]) and
had fewer symptoms than patients receiving OSR (OR 0.38,
95% CI 0.26e0.54; p < .001). However, the number of
emergency patients and patients with poor vessel runoff
did not differ statistically signiﬁcant between the groups.
Comorbidities included hypertension (72%; n ¼ 442),
heart disease (32%; n ¼ 197), hyperlipidemia (43%;
n ¼ 262), and diabetes mellitus (21%; n ¼ 86). A history of
tobacco abuse was noted in 65% (n ¼ 423) of the patients.
Nearly half of the patients presented with bilateral PAA
(46%; n ¼ 281), and in 29% (n ¼ 176) PAA was associated
with abdominal artery aneurysm.
All patients in all studies were treated post-operatively
with double antiplatelet therapy (acetylsalicylic acid, clopi-
dogrel) at least for 1 month, or with oral anticoagulation
plus one antiplatelet medication.
Outcomes of EVR and OSR
After 30 days, graft occlusion rates (9% vs. 2%; OR 3.16, 95%
CI 1.31e7.62 [p ¼ .01]) and re-intervention rates (9% vs.
4%; OR 2.15, 95% CI 1.02e4.55 [p ¼ .04]) were signiﬁcantly
Figure 1. Flowchart of study selection.
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treatment groups, patients required second interventions
for graft thrombosis, bleeding, and wound infections. The
duration of the endovascular intervention (EVR 163 minutes
vs. OSR 345 minutes; MD 182.00, 95% CI 220.90
to 143.10 [p < .001]) and length of hospitalization after
EVR were signiﬁcantly shorter than for OSR (EVR 3.5 days
vs. OSR 7.3 days; MD 3.73, 95% CI 4.74 to 2.72
[p < .001]).
Stent graft complications following EVR were found in
seven patients. One patient was described to have stent
graft migration, combined with type I and III endoleaks. The
patient required re-intervention with the deployment of an
additional endograft.29 Overall, six endoleaks were found in
the cumulative endovascular population: one patient
(endoleak type II) required conversion surgery; two(endoleak type I) required late re-intervention; and the
remaining three (endoleak type II) were treated
conservatively.
There were no statistically signiﬁcant differences be-
tween open and endovascular treatment in the categories
of patient survival, limb loss, and primary patency when
calculated as the HR in a random model (Figs. S1eS3; see
Supplementary material).
After 4 years the cumulative primary patency rates lay
between 63% and 88% after OSR and between 54% and
86% after EVR. Over the complete follow up of all ﬁve
studies (mean length of follow up 33 months, range 1e
156), the summary HR showed no statistically signiﬁcant
differences in the risk of graft thrombosis between the
groups. The summary HR was 1.46 (95% CI 0.92e2.33;
p ¼ .11), indicating slightly reduced patency rates in the
Table 1. Study characteristics.
Study Study design No. of cases
(EVR/OSR)
No. of
emergency
cases
(EVR/OSR)
Mean (range)
length of
follow up (mo)
Operative strategy
Approach: posterior/
medial
PAA: ligature/excision
Graft: vein/prosthesis
Type of
stent grafta
Technical
success of
EVR (%)
Outcomes Score
(max. 9)c
Risk of
bias (RCT)
Quality
of study
Huang et al.
(2014)28
Retrospective,
single center
149 (42/107) 24 (10/14) 31 (1e78) Yes Viabahn 98b 1, 4, 5, 8 5 Low
Pulli et al.
(2013)25
Retrospective,
multicenter
312 (134/178) 40 (10/30) 31 (1e156) Yes Viabahn,
Hemobahn
100 1, 2, 3, 5, 6, 7, 8 5 Low
Stone et al.
(2013)27
Retrospective,
single center
87 (24/63) 27 (7/20) 39 (2e122) Yes Viabahn 100 1, 3, 5, 8 5 Low
Antonello et al.
(2007)23
RCT plus
prospective study,
single center
48 (21/27) None 47 (10e97) Yes Viabahn,
Hemobahn
100 1, 2, 3, 6, 7, 8 7 þ/þ/?/þ/?/?/? Moderate
Curi et al.
(2007)29
Retrospective,
single center
56 (15/41) 5 (0/5) 17 (1e156) Yes Viabahn,
Hemobahn
100 1, 2, 5, 8 5 Low
Total 652 (236/416) 96 (27/69) 33 Yes
Note. Outcomes: 1 ¼ primary patency; 2 ¼ patient survival; 3 ¼ limb salvage; 4 ¼ operative time; 5 ¼ length of hospital stay; 6 ¼ 30 day re-intervention; 7 ¼ 30 day thrombosis; 8 ¼ 30 day
mortality. “?” ¼ unclear risk; “þ” ¼ low risk for the following (in order): random sequence generation (selection bias), allocation concealment (selection bias), blinding (performance bias),
incomplete outcome data (attrition bias), selective reporting (reporting bias), other bias. EVR ¼ endovascular repair; OSR ¼ open surgical repair; RCT ¼ randomized controlled trial;
PAA ¼ popliteal artery aneurysm.
a Viabahn and Hemobahn both manufactured by Gore (Falstaff, AZ, USA).
b Conversion to OSR in one case.
c NO Score for Newcastle Ottawa score.
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Table 2. Grading of Recommendations Assessment, Development and Evaluation (GRADE) evaluation.
Outcomes No. of participants
(studies)
Risk of bias Inconsistency Indirectness Imprecision Publication
bias
Overall quality
of evidence
Primary patency 652 (5) Serious Serious No Serious NA Very low
Limb salvage 448 (3) Serious Serious No Serious NA Very low
Mortality
30 d mortality 637 (5) Serious No No No NA Low
2 y mortality 400 (3) Serious Serious No No NA Very low
Peri-operative details
Operative time 149 (1) Serious NA No No NA Low
Length of hospital stay (d) 447 (4) Serious Serious No No NA Very low
30 d re-intervention 344 (2) Serious No No Serious NA Very low
30 d thrombosis 344 (2) Serious No No Serious NA Very low
Note. GRADE working group levels of evidence: high quality ¼ further research very unlikely to change conﬁdence in estimate of effect;
moderate quality ¼ further research likely to have an important impact on conﬁdence in estimate of effect and may change estimate; low
quality ¼ further research very likely to have an important impact on conﬁdence in estimate of effect and likely to change estimate; very
low quality ¼ very uncertain about estimate. NA ¼ not applicable.
356 M. von Stumm et al.endovascularly treated group compared with the open
surgery group (Fig. 2).
DISCUSSION
This is the largest meta-analysis published to date to
compare EVR and OSR of PAAs. The present ﬁndings suggest
that EVR of PAA is a feasible and safe procedure. EVR was
shown to have primary patency rates equivalent to OSR.
However, only ﬁve studies were included in this meta-
analysis and the quality of evidence was low.Table 4. Operation details.
EVR OSR
Operative time, min (mean  SD) 163  115 345
Length of stay, d (mean  SD) 3.5  1.4a 7.3
30 d graft thrombosis, % (n) 9 (17/191) 2 (7
30 d re-intervention, % (n) 9 (18/191) 4 (1
Note. Signiﬁcant values are given in bold. EVR ¼ endovascular repair; O
CI ¼ conﬁdence interval.
a n ¼ 150.
b n ¼ 327.
Table 3. Baseline patient characteristics.
EVR O
Male 91 (204/223) 9
Age, mean  SD (y) 75  6a 6
Bilateral PAA 48 (97/204) 5
AAA 23 (47/204) 3
Symptoms 37 (78/211) 5
Emergency cases 12 (27/232) 1
Vessel runoff <2 26 (50/191) 3
Coronary artery disease 35 (78/225) 3
Hypertension 72 (161/225) 7
Hyperlipidaemia 45 (94/210) 4
Diabetes mellitus 20 (34/170) 2
Smoking 68 (129/190) 6
Note. Data are presented as % (n) unless otherwise indicated. Signiﬁ
OSR ¼ open surgical repair; OR ¼ odds ratio; MD ¼ mean differen
AAA ¼ abdominal aortic aneurysm.
a n ¼ 223.
b n ¼ 374.The ﬁrst meta-analytic review comparing EVR and OSR of
PAA was published in 2008. Lovegrove et al. analyzed three
studies containing 141 patients (37 EVR, 104 OSR).22,26,29,30
The data from all three studies were included in the present
meta-analysis. No differences were found in the results
between the present analysis and the one performed by
Lovegrove et al.30
In 2014, Joshi et al. published a Cochrane review
comparing EVR and OSR.12 Joshi et al. included only one
study, which is also part of the present analysis.22 Thep OR/MD (95% CI)
 92 <.001 L182.00 (L220.09 to 143.10)
 4.0b <.001 L3.73 (L4.74 to L2.72)
/302) .01 3.16 (1.31e7.62)
4/302) .04 2.15 (1.02e4.55)
SR ¼ open surgical repair; OR ¼ odds ratio; MD ¼mean difference;
SR p OR/MD (95% CI)
5 (356/374) .20 0.65 (0.33e1.27)
8  3b <.001 6.95 (3.98e9.92)
1 (184/362) .71 0.93 (0.62e1.38)
6 (129/362) .92 0.93 (0.24e3.63)
9 (224/378) <.001 0.38 (0.26e0.54)
7 (69/416) .60 0.78 (0.30e1.99)
4 (111/326) .48 0.79 (0.40e1.54)
1 (119/385) .28 1.47 (0.74e2.92)
3 (281/385) .69 1.14 (0.60e2.16)
9 (168/344) .75 1.06 (0.73e1.54)
2 (52/242) .81 0.94 (0.57e1.54)
1 (179/294) .95 1.03 (0.47e2.23)
cant values are highlighted in bold. EVR ¼ endovascular repair;
ce; CI ¼ conﬁdence interval; PAA ¼ popliteal artery aneurysm;
Figure 2. Primary patency following endovascular repair (EVR) and open surgical repair (OSR; complete follow up). Primary patency across
studies: following EVR patients had a slightly increased risk of graft thrombosis compared with OSR patients (non-signiﬁcant difference).
Note. CI ¼ conﬁdence interval.
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sent review, and the researcher drew similar conclusions.
Graft thrombosis was more likely following EVR during
the ﬁrst 30 post-operative days. Reasons for early stent
graft thrombosis include inadequate stent graft expansion,
stent graft kinking, or inappropriate inhibition of platelet
aggregation.31,32 Previously, one of the largest prospective
cohort studies of EVR reported a high incidence of early
stent graft thrombosis.33 Tielliu et al. detected improved
patency rates under dual platelet therapy (aspirin, clopi-
dogrel).33 Although, all patients in the present review were
treated with two antiplatelet medications for at least 1
month or with permanent oral anticoagulation after inter-
vention, stent grafts tended to occlude more often in the
early post-operative phase than venous bypass grafts.
Further development of stent graft material might
diminish the high rate of stent graft thrombosis. The stent
graft material, which is placed into the popliteal artery,
needs to be very ﬂexible. The popliteal artery is bent many
times daily, which is associated with popliteal artery
compression or occlusion.34 Therefore, common complica-
tions of EVR are stent graft thrombosis, migration, kinking,
fractures, and the occurrence of endoleaks.35,36
In 2010, Midy et al. presented higher complication rates
after the use of Wallgraft stent grafts (Boston Scientiﬁc,
Natick, MA, USA) than with Viabahn (Gore) stent grafts in
PAA.10 Apparently, owing to reduced ﬂexibility, Wallgraft
stent grafts occluded more easily and were associated with
more endoleaks.10 In the present meta-analysis only Via-
bahn (Gore) and Hemobahn (Gore) (i.e., no Wallgraft) stent
grafts were used for endovascular stenting. Despite the
better ﬂexibility of stent graft material, patients in the
present review experienced stent graft thrombosis, stent
graft migration, and the formation of endoleaks.
It is not only the mechanical properties of stent grafts
that are under constant development; the surface in con-
tact with blood is also under development: in a recent
study, Lammer et al. provided promising results with regard
to the new generation stent graft with a heparin bonded
surface and contoured proximal edge.37 The researcher
demonstrated signiﬁcant patency beneﬁts for heparin
bonded covered stent grafts compared with bare metal
stent grafts in femoropopliteal artery lesions.37 In contrast,
the new concept of multilayer ﬂow modulating stent grafts,introduced by Thakar and Chaudhuri showed poor results.38
The researcher implanted six multilayer stent grafts in six
patients with PAA. They reported a thrombosis rate of 50%
after 6 weeks.38
The advantages of EVR are low invasiveness, with the
avoidance of general anesthesia; minor blood loss; and a
short duration of intervention. Further major beneﬁts of
this minimally invasive procedure are a short hospitalization
and short recovery times with fewer wound complications.
However, the use of EVR is limited by the patient’s anatomy.
For a successful stent graft implantation, patients with at
least two runoff vessels and suitable proximal and distal
landing zones (2 cm) are preferred.35,39
Despite gaining wide acceptance of EVR for PAA and its
acceptable results, the US Food and Drug Administration
has not yet approved this technique. As a consequence,
many vascular surgeons, even outside the USA, are reluc-
tant to use EVR, especially in younger patients with acute
symptoms. This is reﬂected by the baseline characteristics of
the patients reviewed here: patients receiving EVR were
signiﬁcantly older and less symptomatic than surgically
treated patients, which is in line with the previous litera-
ture.29 Respecting patients’ speciﬁc risk proﬁles, this may
limit the generalizability of the ﬁndings of this review.
Currently, high quality studies comparing the main repair
methods of PAA are lacking. All currently published data on
EVR for PAA come from a heterogeneous patient popula-
tion. Unfortunately, this heterogeneity cannot be investi-
gated statistically at present because the necessary data are
not available. As a consequence of limited evidence, EVR
has not yet been recommended as a routine procedure.
Prospective RCTs comparing EVR and OSR are frequently
called for in the literature.9,27,39 However, the carrying out
of valid randomized trials is complicated owing to the low
prevalence rates of PAA, with long recruitment periods and
divergent study populations. To provide a large number of
patients and appropriate medical evidence, population
based registries need to be established, such as the Swed-
vasc registry in Sweden, or the VASCUNET collaboration
(Europe, Australia, New Zealand).40,41
The results of such a population based register were
recently published by Galiñanes et al.,42 who compared
short-term outcomes after EVR and OSR of PAAs in 2,962
patients in the USA. After 1 and 3 months, EVR was
358 M. von Stumm et al.associated with higher re-intervention rates but did not
offer mortality or cost beneﬁts over OSR.
At the moment, it is not possible to determine the best
treatment method for patients with PAA. Further research
is necessary and long-term results of population based
registries are required. Currently, there is an ongoing
multicenter RCT (NCT01817660) comparing EVR and OSR,
which might bring more clarity to this topic in the future.12
Limitations
The present review has many strengths including the large
sample size and detailed patient information, but it is also
not without weaknesses. First, a comparatively small
number of publications was identiﬁed for inclusion in the
meta-analysis. Second, the selected studies were retro-
spective reviews and did not follow identical study pro-
tocols. Finally, study follow up periods were short and lost
to follow up rates high. Owing to the low quality of primary
studies, the overall quality of evidence was deemed “low”
and “very low”. Therefore, caution should be taken when
drawing conclusions from the data presented.
Conclusion
This systematic review and meta-analysis suggests that
endovascular aneurysm repair may be a safe and efﬁcient
therapeutic method for PAAs with suitable anatomy.
Midterm primary patency rates did not differ between EVR
and OSR, but 30 day re-intervention and thrombosis rates
following EVR were greater than OSR. Currently, the quality
evidence for EVR is low, and for evidence based recom-
mendations on EVR further research is absolutely necessary.
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